Search
for
Sort by
Research 91–120 of 1000+
- Sertoliform Endometrioid Carcinomas of the Right Ovary
- ANDROGEN AND CORTISOL SECRETING ADRENOCORTICAL ONCOCYTOMA WITTH UNCERTAIN MALIGNANT POTENTIAL
- Prematüre Pubarş Olgularının Değerlendirilmesi: Tek Merkez Deneyimi
- Evaluation of Premature Pubarche Cases: A Single CenterExperience
- Модели оценивания профессиональной деятельности учителя
- In vivo and in vitro exposure to free fatty acids induce increased androgen production in animal models: a potential pathogenic factor of the polycystic ovary syndrome
- Measurement and comparison of various androgen levels in women with severe acne, hirsutism, and androgenic alopecia
- Androgenic hormone profile in patients with androgenetic alopecia
- Das Cushing-Syndrom im Spiegel der Haut
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- Androgenic Hormone Profile of Adult Women with Acne
- Role of Dehydroepiandrosterone (DHEA) in the Pathophysiology and Clinical Manifestations of Polycystic Ovary Syndrome (PCOS)
- Characterization of recombinant human liver dehydroepiandrosterone sulfotransferase with minoxidil as the substrate
- The Hormonal Background of Hair Loss in Non-Scarring Alopecias
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- A Randomized Trial of Oral DHEA Treatment for Sexual Function, Well-Being, and Menopausal Symptoms in Postmenopausal Women with Low Libido
- Prescribing testosterone and DHEA: The role of androgens in women
- DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase
- Sulfatase inhibitors: a patent review
- An isotope dilution-liquid chromatography-tandem mass spectrometry-based candidate reference measurement procedure for the quantification of dehydroepiandrosterone sulfate in human serum and plasma
- DHEA and TNF-α: Key Factors in Managing Polycystic Ovary Syndrome in Iraqi Females
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Gut–ovary axis and multiomic insights into PCOS in a DHEA-induced rat model
- Is dehydroepiandrosterone a hormone?
- Androgen replacement therapy in women
- Effect of neurosteroid dehydroepiandrosterone on the higher nervous activity of old non-human primates
- Pharmakokinetik und Biokonversion von Dehydroepiandrosteron nach Dexamethason-Vorbehandlung bei Frauen mit dem Syndrom der polyzystischen Ovarien
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Efficacy and safety of systemic spironolactone for acne in female patients in Sulaymaniyah teaching center of dermatology